drugset / Trial / NCT02371941
Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled study of oral cromolyn sodium when made into a viscous preparation for the treatment of eosinophilic esophagitis.
Timeline
- Start
- 2014-12
- Primary completion
- 2017-07
- Completion
- 2017-12
Outcome
Missed primary endpoint
paper Cromolyn, when mixed into a viscous preparation, did not significantly decrease esophageal eosinophilia. PMID 29544738 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cromolyn | Small molecule | 100 mg | Oral |
| Subject | Cromolyn | Small molecule | 200 mg | Oral |